Relmada Therapeutics obtained global rights to market dextromethadone for treating CNS diseases Read more
OBI Pharma confirms FDA’s clearance of IND for Phase 1 Study of Monoclonal Antibody Cancer Immunotherapy Read more
MiMedx enrolls first patients in the Phase 3 IND Clinical Trial for treating Achilles Tendonitis Read more
FDA Commissioner Scott Gottlieb,M.D., vows to enhance clarity of Clinical Trial information Read more